首页> 外文期刊>Journal of Clinical Microbiology >Molecular Quantification of Respiratory Syncytial Virus in Respiratory Samples: Reliable Detection during the Initial Phase of Infection
【24h】

Molecular Quantification of Respiratory Syncytial Virus in Respiratory Samples: Reliable Detection during the Initial Phase of Infection

机译:呼吸道样本中呼吸道合胞病毒的分子定量:感染初始阶段的可靠检测。

获取原文
           

摘要

Quantitative real-time PCR for the detection of respiratory syncytial virus (RSV) RNA is increasingly used to study the causal role of RSV in lower airway disease. The objective of our study was to evaluate variations in RSV RNA loads at different steps in the RNA quantification process: (i) variation in RSV RNA load within one sample (step 1), (ii) variation in the load in samples from patients who were sampled twice on the same day (step 2), and (iii) variation in the load between simultaneously taken nasopharyngeal aspirate (NPA) samples and tracheal aspirate (TA) samples (step 3). Thirty-two infants with RSV infection at the pediatric intensive care unit (PICU) were included. NPA and TA samples were taken three times a week during ventilation and were not diluted. Intrasample variation (step 1) was shown to be minimal (<0.5 log10 particles/ml). Intraday variation (step 2) was the lowest for samples with high viral loads (95% limits of agreement, ?1.3 to +0.9 log10), whereas it increased for samples with relatively lower viral loads (viral load, <6.0 log10 particles/ml; n = 138 sample pairs from 20 patients). RSV loads in NPA and TA samples (step 3) were found to be the most comparable during the early phase of infection (95% limits of agreement, ?1.5 to +1.4 log10). The variation increased during the late phase of infection (i.e., in follow-up samples), with the loads in NPA samples remaining significantly higher than the loads in TA samples (n = 138 sample pairs from 31 patients). In conclusion, quantitative detection of RSV RNA in undiluted mucus is a reliable method to quantify viral loads. Nasopharyngeal aspirate samples collected in the initial phase of infection can be used to predict RSV RNA loads in the lower airways.
机译:用于检测呼吸道合胞病毒(RSV)RNA的定量实时PCR越来越多地用于研究RSV在下呼吸道疾病中的因果作用。我们研究的目的是评估RNA定量过程中不同步骤的RSV RNA载量的变化:(i)一个样品(步骤1)中RSV RNA载量的变化,(ii)那些在同一天两次采样(步骤2),并且(iii)同时采集的鼻咽抽吸物(NPA)和气管抽吸物(TA)样品之间的负荷变化(步骤3)。小儿重症监护病房(PICU)收治了32例RSV感染婴儿。 NPA和TA样品在通风期间每周采集三次,未稀释。样品内变化(步骤1)显示为最小(<0.5 log 10 颗粒/ ml)。对于高病毒载量(协议限制的95%,? 1.3至+0.9 log 10 ),当日变化(步骤2)最低,而对于病毒载量相对较低(病毒)的样品,其日内变化最低负荷,<6.0 log 10 颗粒/ ml; n = 20位患者的138个样本对。发现NPA和TA样品中的RSV负荷(第3步)在感染的早期阶段具有最高的可比性(协议限制的95%,? 1.5至+1.4 log 10 )。在感染后期(即随访样本中),变异增加,NPA样本中的载量仍显着高于TA样本中的载量( n = 31对患者的138个样本对) )。总之,未稀释的粘液中RSV RNA的定量检测是定量病毒载量的可靠方法。在感染初期收集的鼻咽抽吸物样本可用于预测下呼吸道的RSV RNA负荷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号